ArticleAdvanced healthcare materials2026

Temporal Immune and Metabolic Shifts Drive the Anti-Tumor Efficacy of Resiquimod-Loaded Nanoparticles in Peritoneal Carcinomatosis.

Vanessa Chan et al.PubMed ↗Publisher ↗

No numbers read from the abstract.